Cardioprotective effects of deferoxamine in acute and subacute cardiotoxicities of doxorubicin: a randomized clinical trial

Abstract Background Cardiotoxicity is a major concern following doxorubicin (DOX) use in the treatment of malignancies. We aimed to investigate whether deferoxamine (DFO) can prevent acute cardiotoxicity in children with cancer who were treated with DOX as part of their chemotherapy. Results Sixty-t...

Full description

Bibliographic Details
Published in:	The Egyptian Heart Journal
Main Authors:	Kosar Rahimi, Hamid Amoozgar, Soheila Zareifar, Mahdi Shahriari, Omid Reza Zekavat, Mehran Karimi, Gholamreza Fathpour, Fazl Saleh, Nader Shakibazad, Shayan Bordbar, Mohammadreza Bordbar
Format:	Article
Language:	English
Published:	SpringerOpen 2023-03-01
Subjects:	Cancer Cardiotoxicity Deferoxamine Doxorubicin Pediatric
Online Access:	https://doi.org/10.1186/s43044-023-00347-4

Similar Items

Cardioprotective potential of protocatechuic acid against doxorubicin-induced cardiotoxicity in rats
by: Leila Safaeian, et al.
Published: (2025-01-01)

The Role of Flavonoids as a Cardioprotective Strategy against Doxorubicin-Induced Cardiotoxicity: A Review
by: Rony Abdi Syahputra, et al.
Published: (2022-02-01)

The role of doxorubicin in the formation of cardiotoxicity is a consensus statement. Part II. Cardiotoxicity of doxorubicin unrelated to myocytes and cardioprotection strategy (review)
by: D. A. Andreev, et al.
Published: (2024-09-01)

Cardioprotective effect of vanillic acid against doxorubicin-induced cardiotoxicity in rat
by: Bahar Baniahmad, et al.
Published: (2020-01-01)

Improving Captopril cardioprotective activities against Doxorubicin induced cardiotoxicity by co-administration with allicin
by: Esam M. Aboubakr*, et al.
Published: (2024-01-01)

Mechanistic Insights into Flavonoid Subclasses as Cardioprotective Agents Against Doxorubicin-Induced Cardiotoxicity: A Comprehensive Review
by: Shang W, et al.
Published: (2025-07-01)

Cardioprotective effects of Rhododendron arboreum leaf extract against Doxorubicin-induced cardiotoxicity in Wistar rats by modulating electrocardiographic and cardiac biomarkers
by: Adersikha Pradhan, et al.
Published: (2023-11-01)

Lipidomics application to explain acute cardiotoxicity induced by doxorubicin
by: Lubna Zuhair Abdul Karim, et al.
Published: (2019-12-01)

Dapagliflozin May Protect Against Doxorubicin-Induced Cardiotoxicity
by: Sebahat Ulusan, et al.
Published: (2023-05-01)

Investigation of the efficacy of tyrosol on doxorubicin-induced acute cardiotoxicity in rats
by: Mustafa Cellat, et al.
Published: (2022-09-01)

Cardioprotective effects of sodium thiosulfate against doxorubicin-induced cardiotoxicity in male rats
by: Maryam Shekari, et al.
Published: (2022-05-01)

The role of hesperidin as a cardioprotective strategy against doxorubicin-induced cardiotoxicity: The antioxidant, anti-inflammatory, antiapoptotic, and cytoprotective potentials
by: Fawiziah K. Alharbi, et al.
Published: (2023-12-01)

Effect of pimobendan on cytokine levels in doxorubicin-induced cardiotoxicity
by: Burak Dik, et al.

Cardiotoxicity of doxorubicin – causes, prevention, prospects
by: Paweł Wesołowski, et al.
Published: (2022-11-01)

Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity
by: Manrose Singh, et al.
Published: (2022-01-01)

Apigenin-coated gold nanoparticles as a cardioprotective strategy against doxorubicin-induced cardiotoxicity in male rats via reducing apoptosis
by: Zeynab Sharifiaghdam, et al.
Published: (2023-03-01)

Synergistic cardioprotective effects of melatonin and deferoxamine through the improvement of ferritinophagy in doxorubicin-induced acute cardiotoxicity
by: Mira Hanna, et al.
Published: (2022-11-01)

Vitamin C as a Cardioprotective Agent Against Doxorubicin‐Induced Cardiotoxicity
by: Hamdi Nsairat, et al.
Published: (2025-08-01)

Investigate if Metoprolol and Troxerutin Could Prevent Cardiotoxicity Mitigated by Doxorubicin
by: Fouad Zeidan Hamzah, et al.
Published: (2025-07-01)

Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
by: Irwin K. Cheah, et al.
Published: (2023-01-01)

Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction
by: Maria Isabel Camara Planek, et al.
Published: (2020-07-01)

Cardiotoxicity of doxorubicin: Causes, diagnosis, consequences and possibilities of prevention
by: Radić Jelena P., et al.
Published: (2022-01-01)

Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity
by: Himani Kumari, et al.
Published: (2020-05-01)

Cardioprotective potential of botanical agents against anthracycline-induced cardiotoxicity
by: Parisa Firoozbakhsh, et al.
Published: (2024-05-01)

Pathophysiology of Doxorubicin-Mediated Cardiotoxicity
by: Roberto Arrigoni, et al.
Published: (2025-04-01)

Anti-apoptotic effects of minocycline on doxorubicin-induced cardiotoxicity in male Wistar rats
by: Hossein Piri, et al.
Published: (2023-12-01)

Cardioprotective Effect of Quercetin and Sitagliptin in Doxorubicin-Induced Cardiac Toxicity in Rats
by: Aziz TA
Published: (2021-03-01)

CREG1 attenuates doxorubicin-induced cardiotoxicity by inhibiting the ferroptosis of cardiomyocytes
by: Dan Liu, et al.
Published: (2024-09-01)

Luteolin Attenuates Doxorubicin-Induced Cardiotoxicity Through Promoting Mitochondrial Autophagy
by: Haixia Xu, et al.
Published: (2020-02-01)

Mitophagy in Doxorubicin-Induced Cardiotoxicity: Insights into Molecular Biology and Novel Therapeutic Strategies
by: Heng Zhang, et al.
Published: (2024-12-01)

Hyperhomocysteinaemia Promotes Doxorubicin-Induced Cardiotoxicity in Mice
by: Rui Fan, et al.
Published: (2023-08-01)

Shikimic acid protects against doxorubicin-induced cardiotoxicity in rats
by: Maha Abdullah Alwaili, et al.
Published: (2025-03-01)

The Protective Effect of Metformin Against Doxorubicin Induced Cardiotoxicity in Rabbits
by: Mohammed Hussein shaty, et al.
Published: (2019-03-01)

Doxorubicin‐induced and trastuzumab‐induced cardiotoxicity in mice is not prevented by metoprolol
by: Martin Nicol, et al.
Published: (2021-04-01)

Metabolomic profiling and biomarker identification for early detection and therapeutic targeting of doxorubicin-induced cardiotoxicity
by: Jingjing Ding, et al.
Published: (2025-04-01)

Potential Roles of Melatonin in Doxorubicin-Induced Cardiotoxicity: From Cellular Mechanisms to Clinical Application
by: Tanawat Attachaipanich, et al.
Published: (2023-02-01)

Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer
by: Cochera F, et al.
Published: (2018-07-01)

Recent progress in the role of endogenous metal ions in doxorubicin-induced cardiotoxicity
by: Ni Zhou, et al.
Published: (2023-12-01)

Cardioprotective effect of Saussurea involucrata injection against Doxorubicin-induced cardiotoxicity by network pharmacology analysis and experimental verification
by: Wang Ding, et al.
Published: (2024-12-01)

Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children’s Oncology Group
by: Lisa M. Kopp, et al.
Published: (2019-10-01)